Oct 12, 2023 Press Releases BioGenerator Company SentiAR Announces Second FDA Clearance for CommandEP™ Interface
Sep 27, 2023 BioGenerator Company Omniose Lands $3.0 Million to Develop Vaccines against Group B Streptococcus
Sep 19, 2023 In the News BioGenerator Company Aclaris Announces Positive Phase 1 Data for ITK/JAK3 inhibitor
Aug 26, 2023 In the News Managing Director of BioGenerator Ventures, Matt Helms, Builds Unique Ag-Food Business
Aug 15, 2023 In the News BioGenerator Company Wugen Begins Phase 1 Clinical Trial of Allogeneic Memory Natural Killer (NK) Cell Therapy
May 18, 2023 In the News BioGenerator Company Immunophotonics Receives Green Light from FDA to Open IND
